drugset
drugset / Trial / NCT00569400

Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes

NCT00569400 ↗

Phase 3 Completed 241 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Asia and Oceania. The aim of this trial is to compare the efficacy and safety of human insulin produced by the current process and the NN729 process in type 1 diabetes.

Timeline

Start
2003-05-01
Primary completion
2004-01-19
Completion
2004-01-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic — —

Indications

type 1 diabetes mellitus